Insights & Discussion
Pumpkin seeds, in combination with other plants, show potential as an alternative treatment method for diabetes mellitus.
Using a comprehensive review of literature, the study identified the interventions and impacts of incorporating pumpkin seeds in the treatment of diabetes mellitus. A series of experiments on lab animals were performed where the consumption of pumpkin seeds was combined with other plant supplements. The objective of these experiments was to observe any potential hypoglycemic activity that could then be utilised in controlling diabetes.
The results derived from these experiments showed that pumpkin seeds present significant advantages in promoting and maintaining health, particularly in relation to diabetes mellitus. The evidence suggests that the unique combination of pumpkin seeds with other plant substances resulted in hypoglycemic activity. This finding posits pumpkin seeds as a viable option for complementary therapy in treating individuals with diabetes mellitus, by providing a more natural alternative to conventional drugs.
Discover Related Insights
Pumpkin seeds and their extracts, including Trigonelline, Nicotinic acid, and D-chiro-inositol, offer potential for controlling blood sugar levels in diabetes patients.
2014 Critical Reviews in Food Science and Nutrition The Hypoglycemic Effect of Pumpkin Seeds, Trigonelline (TRG), Nicotinic Acid (NA), and D-Chiro-inositol (DCI) in Controlling Glycemic Levels in Diabetes Mellitus Adams GG, Imran S, Wang S, Mohammad A, Kok MS, Gray DA, et al.
Experimental Study Hypoglycemic Effect Pumpkin Seed Type 2 Diabetes
The study investigated the hypoglycemic properties of pumpkins, specifically focusing on the seeds. A variety of biologically active ingredients found in pumpkins were analyzed, these include polysaccharides, para-aminobenzoic acid, fixed oils, sterols, proteins, and peptides, with an emphasis on the macromolecules such as Trigonelline, Nicotinic acid, and D-chiro-inositol. A key aspect of the methodology was examining the role these chemicals play in maintaining glycemic control, by investigating the effects of fruit pulp, ungerminated seed oil, and protein from germinated seeds.
In the discussion of results, the study indicated that chemicals within pumpkins do have hypoglycemic properties, suggesting the potential use of pumpkins, particularly their seeds, in controlling or managing blood sugar levels in diabetes patients. Specific macromolecules within the seeds, Trigonelline, Nicotinic acid, and D-chiro-inositol, also suggested hypoglycemic properties. These results underline the potential that pumpkin and its biologically active ingredients could offer an innovative approach to dealing with diabetes mellitus.